InvestorsHub Logo

locicat1

06/01/20 1:50 PM

#15090 RE: H1C #15089

Once again, a most excellent and accurate response/assessment of the the issues facing IMUN!!

Ej23ny

06/01/20 2:39 PM

#15093 RE: H1C #15089

I respectfully disagree with you. If LDN is patient protected the researchers cannot file for the approval. Does not matter who completed the trial.